Transparency Reporting
The purpose of this section is to report information required under the Medicines Australia Code of Conduct with respect to the interactions between the Australian affiliate of Gilead Sciences and Australian based HCPs.
From 30 August 2019, this information will now be held in a database, administered by Medicines Australia. This database is designed to be searchable as well as downloaded as a CSV file.
For further information about the details in the report, or to search the database, please visit www.DisclosureAustralia.com.au.
Australian HCP TOV Report 01 Nov 2019 – 30 Apr 2020 PDF
Australian HCP TOV Report 01 Nov 2019 – 30 Apr 2020 CSV
Australian HCP TOV Report 01 May 2019 31 Oct 2019 PDF
Australian HCP TOV Report 01 May 2019 31 Oct 2019 CSV
Australian HCP TOV Report 01 Nov 2018 30 Apr 2019 PDF
Australian HCP TOV Report 01 Nov 2018 - 30 Apr 2019 CSV
Australian HCP TOV Report 01 May 2018 – 31 Oct 2018(PDF)
Australian HCP TOV Report 01 May 2018 – 31 Oct 2018 (CSV)
Australian HCP TOV Report 01 November 2017 - 30 April 2018 (PDF)
Australian HCP TOV Report 01 November 2017 - 30 April 2018 (CSV)